SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : NASI (North American Scientific, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BDR who wrote (487)3/22/1998 7:59:00 PM
From: mantle7  Read Replies (2) of 658
 
I would be curious to know what data you are relying on which indicates a peak in prostate cancer cases. I would have expected a reasonable growth based largely on demographics. In addition, due tho PSA testing, prostate cancer is being detected much earlier which is great for the seed business. The earlier one detects prostate cancer the greater the likelihood the cancer is still within the prostate capsule and thus is a great candidate for seeds.
I would be curious to also know how old the data is. Frequently, available discharge data is at least 3-4 years old and thus might not reflect recent growth in seed implantation at the possible expense of watchful waiting.

Can anyone explain the rarified air valuations of NASI and INIS? I would have thought that their distribution partners Mentor and Imagyn would have also participated in the fun, but they have been sitting out. Makes no sense to me. I view the production side of the equation as somewhat unattractive due to the high fixed costs and limited capacity flexibility. Eventually there will be a war over who can be the lowest cost supplier of a commodity product. What am I missing?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext